Back
Catalyst Pharmaceuticals Quote, Financials, Valuation and Earnings
The #1 free indicator I've used for 30 years
The indicator is free... and the 23-page book I wrote for you is also free.
Buy
56
CPRX
Catalyst Pharmaceuticals
Last Price:
15.82
Seasonality Move:
34.21%
7 Day Trial
ALL ACCESS PASS
$
7
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion SuperprojectCatalyst Pharmaceuticals Price Quote
$15.82
+0.05 (+0.32%)
(Updated: July 2, 2024 at 6:55 PM ET)
Catalyst Pharmaceuticals Key Stats
Buy
56
Catalyst Pharmaceuticals (CPRX)
is a Buy
Day range:
$15.49 - $15.97
52-week range:
$11.55 - $17.50
Dividend yield:
0%
P/E ratio:
25.03
P/S ratio:
4.38
P/B ratio:
3.32%
Volume:
835.7K
Avg. volume:
1.2M
1-year change:
17.34%
Market cap:
$1.9B
Revenue:
$398.2M
EPS:
$0.54
How Much Does Catalyst Pharmaceuticals Make?
-
How Much Are Catalyst Pharmaceuticals's Sales Annually?
CPRX Revenues are $398.2M -
How Much Profit Does Catalyst Pharmaceuticals's Make A Year?
CPRX net income is $71.4M
Is Catalyst Pharmaceuticals Growing As A Company?
-
What Is Catalyst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.15% -
What Is Catalyst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.27%
Catalyst Pharmaceuticals Stock Price Performance
-
Did Catalyst Pharmaceuticals Stock Go Up Last Month?
Catalyst Pharmaceuticals share price went down by -2.47% last month -
Did CPRX's Share Price Rise Over The Last Year?
CPRX share price rose by 17.34% over the past 1 year
What Is Catalyst Pharmaceuticals 52-Week High & Low?
-
What Is Catalyst Pharmaceuticals’s 52-Week High Share Price?
Catalyst Pharmaceuticals has traded as high as $17.50 over the past 52 weeks -
What Is Catalyst Pharmaceuticals’s 52-Week Low Share Price?
Catalyst Pharmaceuticals has traded as low as $11.55 over the past 52 weeks
Catalyst Pharmaceuticals Price To Free Cash Flow
-
Is Catalyst Pharmaceuticals Stock Overvalued?
Catalyst Pharmaceuticals is trading at a price to free cash flow ratio of 22.10 -
Is Catalyst Pharmaceuticals Stock Undervalued?
Catalyst Pharmaceuticals EV to Free Cash Flow ratio is 19.03 -
What Is Catalyst Pharmaceuticals’s Price Earnings Growth Ratio?
CPRX PEG ratio is 0.00 -
Is Catalyst Pharmaceuticals Trading At A Premium To Earnings?
Catalyst Pharmaceuticals EV to EBIT ratio is 19.82
Is It Risky To Buy Catalyst Pharmaceuticals?
-
How Much Debt Does Catalyst Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Catalyst Pharmaceuticals Have?
Cash and short term investments quarterly total is $310.4M -
What Is Catalyst Pharmaceuticals’s Book Value Per Share?
Book value per share is 4.76
Is Catalyst Pharmaceuticals Cash Flow Positive?
-
What Is CPRX Cash Flow From Operations?
Cash flow from operations (TTM) is $163.5M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $130M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$131.3M
Catalyst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CPRX return on invested capital is 16.22% -
What Is Catalyst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 13.67% -
What Is CPRX Return On Equity?
ROE is a measure of profitability and is 16.22%
Catalyst Pharmaceuticals Earnings Date & Stock Price
-
What Is Catalyst Pharmaceuticals's Stock Price Today?
A single share of CPRX can be purchased today for 15.77 -
What Is Catalyst Pharmaceuticals’s Stock Symbol?
Catalyst Pharmaceuticals trades on the nasdaq under the ticker symbol: CPRX -
When Is Catalyst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Catalyst Pharmaceuticals is scheduled on August 9, 2024 -
When Is CPRX's next ex-dividend date?
Catalyst Pharmaceuticals's next ex-dividend date is May 30, 2020 -
How To Buy Catalyst Pharmaceuticals Stock?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Catalyst Pharmaceuticals Competitors
-
Who Are Catalyst Pharmaceuticals's Competitors?
Below is a list of companies who compete with Catalyst Pharmaceuticals or are related in some way:
Catalyst Pharmaceuticals Dividend Yield
Data Unavailable
Catalyst Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -26.92% | 25% |
| Revenue: | 15.4% | -0.27% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 27.29 |
| Upside from Last Price: | 73.02% |